companies working on glp-1 drugs Costs Explained: Managing Coverage Challenges 2025’s Breakthrough GLP-1 Obesity Treatments:
Description
only the branding, approval indication, and sometimes pricing differ

Berberine : Can cause digestive issues such as diarrhea or constipation when used in high amounts

Arda-Pirincci P, Bolkent S (2011) The role of glucagon-like peptide-2 on apoptosis, cell proliferation, and oxidant-antioxidant system at a mouse model of intestinal injury induced by tumor necrosis factor-alpha/actinomycin D
Almandoz, J
F., Mesquita L

This supports the conclusions of Huang et al., that satiety (and by extension efficacy) and adverse events can be dissociated (76) and the clinical data outlined above
